Latest News and Press Releases
Want to stay updated on the latest news?
-
13. november 2025 Meddelelse nr. 24 DENNE MEDDELELSE MÅ IKKE OFFENTLIGGØRES, PUBLICERES ELLER DISTRIBUERES, HVERKEN DIREKTE ELLER INDIREKTE, I ELLER TIL USA, CANADA, AUSTRALIEN, JAPAN ELLER...
-
BioPorto Executes on its Financing Strategy- BioPorto A/S initiates pre-subscribed private placement
13 November 2025 Announcement no. 24 THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR...
-
4. november, 2025Meddelelse nr. 23 Opdatering af forretningsstrategi – Strategien "Forward", aspirationer frem mod 2028 og finansieringsbehov KØBENHAVN, DANMARK, 4. november, 2025, (GLOBE NEWSWIRE)...
-
November 4, 2025Announcement no. 23 Business Strategy Update – the “Forward” Strategic Direction, Aspirations towards 2028 and Funding Needs Copenhagen, Denmark, November 4, 2025, (GLOBE NEWSWIRE) –...
-
4. november, 2025 Meddelelse nr. 22 Forudgående offentliggørelse af de finansielle nøgletal for 3. kvartal 2025 og reviderede forventninger til...
-
November 4, 2025 Announcement no. 22 Pre-announcement of the Key Financial Results for Third Quarter 2025 and Revised Guidance for 2025 Copenhagen,...
-
4. november, 2025Meddelelse nr. 21 Statusopdatering på BioPortos kliniske studie for voksne KØBENHAVN, DANMARK, 4. november – BioPorto A/S (BioPorto eller Selskabet) (CPH:BIOPOR), annoncerede i...
-
November 4, 2025Announcement no. 21 Progress Update on BioPorto’s Adult Clinical Study Copenhagen, Denmark, November 4, 2025, (GLOBE NEWSWIRE) – BioPorto A/S (“BioPorto” or the “Company”)...
-
26. september, 2025Meddelelse BioPorto sponsorerer konferencer om pædiatrisk intensiv behandling med præsentation af nye videnskabelige data om NGAL KØBENHAVN, DANMARK og BOSTON, MA, USA, 26....
-
September 26, 2025News Release BioPorto Sponsors Conferences on Pediatric Critical Care with New NGAL Scientific Data Presented COPENHAGEN, DENMARK and BOSTON, MA, USA, September 26 – BioPorto A/S...